Tonix Pharmaceuticals

Tonix Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies to prevent and treat a range of health conditions, primarily central nervous system disorders, immunology conditions, infectious diseases, and rare diseases. Their pipeline includes both small molecules and biologics, with a diverse range of product candidates currently in various stages of development from preclinical to Phase III. Tonix is committed to advancing its innovative programs through internal research and development efforts, as well as strategic collaborations with government institutions, academic research organizations, and other biotech companies.

Beyond its research efforts, Tonix has two marketed products, Zembrace® SymTouch® (sumatriptan injection) and Tosymra® (sumatriptan nasal spray), which are both indicated for the treatment of acute migraine with or without aura in adults. The company has a strong focus on improving patient care and public health, with a particular emphasis on addressing unmet needs in areas like fibromyalgia, cocaine intoxication, organ transplant rejection, and infectious diseases like smallpox and monkeypox.

Tonix Pharmaceuticals is a biopharmaceutical company dedicated to improving population health by developing innovative therapies and vaccines that address unmet needs in central nervous system disorders, immunology, infectious diseases, and rare diseases. Through a combination of in-house expertise and strategic collaborations, Tonix leverages its integrated development engine to advance innovative programs across multiple therapeutic areas into the clinic, ultimately aiming to bring safer and more effective treatments to market.

Tonix Pharmaceuticals promotes a culture of innovation, collaboration, and commitment to improving patient health. They foster a collaborative environment, bringing together passionate professionals with diverse expertise to advance their pipeline of programs. Their focus on developing innovative therapies for unmet needs, particularly in the areas of central nervous system disorders, immunology, infectious diseases, and rare diseases, drives their dedication and commitment to improving the lives of millions.